Sandra Levy
ARTICLES BY THIS AUTHOR
- 4/17/2024
Placer.ai weighs in on Q1 2024 retail sector performance
Retail’s positive Q1 performance leaves plenty of room for optimism about what’s in store for the rest of 2024, Pacer.ai's Q1 study finds. - 4/17/2024
Upsher-Smith previews expansion of rare disease portfolio at 2024 AAN annual meeting
Upsher-Smith has broadened its offerings to include Vigadrone (vigabatrin) Tablets, 500 mg. Torpenz Tablets, a branded-generic everolimus tablet, will soon be available to prescribers and patients. - 4/17/2024
Fresenius debuts Actemra biosimilar
Tyenne, for use in the treatment of chronic autoimmune diseases, is available in an intravenous formulation. - 4/17/2024
CRN adopts new guidelines for melatonin supplements, gummy supplements
The guidelines center around formulation, labeling and packaging of melatonin and gummy supplements. - 4/17/2024
CVS Health expands pharmacy tuition assistance, scholarship programs
CVS Health is offering an enhanced Pharm.D. tuition assistance program for eligible interns and a new scholarship for pharmacy students nationwide. - 4/16/2024
Hy-Vee to acquire Strack & Van Til Food Market chain
The acquisition will add 22 stores to Hy-Vee’s portfolio. - 4/16/2024
Giant releases 3rd annual community impact report
Giant's annual impact report highlights its 2023 efforts around its purpose of connecting families for a better future. - 4/16/2024
Strides Pharma obtains FDA OK for generic Prozac
Fluoxetine is used for the treatment of major depressive disorder, obsessive-compulsive disorder, bulimia nervosa and panic disorder, with or without agoraphobia. - 4/16/2024
Meijer donates $250K to Council of the Great Lakes Region Foundation
The donation will help improve water and wildlife quality in river corridors throughout Wisconsin. - 4/16/2024
ANI debuts generic Fleqsuvy
Generic Fleqsuvy is a treatment for spasticity from multiple sclerosis, spinal cord injuries and other spinal cord diseases.
